Skip to main content
. 2024 Oct 8;22:428. doi: 10.1186/s12916-024-03620-8

Fig. 1.

Fig. 1

Study design (A) and patient disposition (B). Data cut-off: April 8, 2022. Orange shading in top panel shows the patient subgroup included in the present integrated analysis. EGFR epidermal growth factor receptor